VIVANI MEDICAL INC (VANI) Stock Price & Overview

NASDAQ:VANI • US92854B1098

Current stock price

1.2499 USD
+0.15 (+13.63%)
Last:

The current stock price of VANI is 1.2499 USD. Today VANI is up by 13.63%. In the past month the price decreased by -5.98%. In the past year, price increased by 0.92%.

VANI Key Statistics

52-Week Range0.9054 - 1.92
Current VANI stock price positioned within its 52-week range.
1-Month Range1.075 - 1.34
Current VANI stock price positioned within its 1-month range.
Market Cap
101.504M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.45
Dividend Yield
N/A

VANI Stock Performance

Today
+13.63%
1 Week
-5.98%
1 Month
-5.98%
3 Months
-18.52%
Longer-term
6 Months -9.09%
1 Year +0.92%
2 Years -40.54%
3 Years +10.00%
5 Years N/A
10 Years N/A

VANI Stock Chart

VIVANI MEDICAL INC / VANI Daily stock chart

VANI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to VANI. When comparing the yearly performance of all stocks, VANI is a bad performer in the overall market: 75.1% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

VANI Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to VANI. The financial health of VANI is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VANI Earnings

Next Earnings DateMar 26, 2026
Last Earnings DateNov 13, 2025
PeriodQ3 / 2025
EPS Reported-$0.11
Revenue Reported
EPS Surprise 1.96%
Revenue Surprise %

VANI Forecast & Estimates

9 analysts have analysed VANI and the average price target is 5.1 USD. This implies a price increase of 308.03% is expected in the next year compared to the current price of 1.2499.


Analysts
Analysts82.22
Price Target5.1 (308.03%)
EPS Next Y4.95%
Revenue Next YearN/A

VANI Groups

Sector & Classification

VANI Financial Highlights

Over the last trailing twelve months VANI reported a non-GAAP Earnings per Share(EPS) of -0.45. The EPS decreased by 0% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-26.03M
Industry RankSector Rank
PM (TTM) N/A
ROA -103.91%
ROE -1988.24%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%N/A
EPS 1Y (TTM)0%
Revenue 1Y (TTM)N/A

VANI Ownership

Ownership
Inst Owners6.72%
Shares81.21M
Float52.13M
Ins Owners44.11%
Short Float %0.56%
Short Ratio0.9

VANI Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.01187.722B
ISRG INTUITIVE SURGICAL INC47.31167.678B
SYK STRYKER CORP22.98128.879B
BSX BOSTON SCIENTIFIC CORP19.87102.581B
EW EDWARDS LIFESCIENCES CORP27.6947.515B
IDXX IDEXX LABORATORIES INC39.3345.688B
BDX BECTON DICKINSON AND CO11.8445.376B
RMD RESMED INC18.7533.629B
GEHC GE HEALTHCARE TECHNOLOGY13.9232.253B
DXCM DEXCOM INC26.0824.723B
ZBH ZIMMER BIOMET HOLDINGS INC11.0318.235B
HOLX HOLOGIC INC15.3216.77B
PODD INSULET CORP34.8815.477B

About VANI

Company Profile

VANI logo image Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. The company is headquartered in Alameda, California and currently employs 42 full-time employees. The company went IPO on 2014-12-05. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

Company Info

IPO: 2014-12-05

VIVANI MEDICAL INC

1350 S. Loop Road

Alameda CALIFORNIA US

Employees: 42

VANI Company Website

VANI Investor Relations

Phone: 14155068462

VIVANI MEDICAL INC / VANI FAQ

Can you describe the business of VIVANI MEDICAL INC?

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. The company is headquartered in Alameda, California and currently employs 42 full-time employees. The company went IPO on 2014-12-05. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.


What is the current price of VANI stock?

The current stock price of VANI is 1.2499 USD. The price increased by 13.63% in the last trading session.


What is the dividend status of VIVANI MEDICAL INC?

VANI does not pay a dividend.


What is the ChartMill technical and fundamental rating of VANI stock?

VANI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the sector and industry classification for VIVANI MEDICAL INC?

VIVANI MEDICAL INC (VANI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


How many employees does VIVANI MEDICAL INC have?

VIVANI MEDICAL INC (VANI) currently has 42 employees.


What is the market capitalization of VANI stock?

VIVANI MEDICAL INC (VANI) has a market capitalization of 101.50M USD. This makes VANI a Micro Cap stock.